295 related articles for article (PubMed ID: 19765730)
1. Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.
Xie B; Xing R; Chen P; Gou Y; Li S; Xiao J; Dong J
J Surg Res; 2010 Aug; 162(2):231-8. PubMed ID: 19765730
[TBL] [Abstract][Full Text] [Related]
2. [Effects of c-met-siRNA on the growth and invasion of hepatocellular carcinoma MHCC97-H cells].
Xie B; Tang DG; Dong JH
Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):499-504. PubMed ID: 16867270
[TBL] [Abstract][Full Text] [Related]
3. [The influence of downregulation of ezrin expression by RNA interference on the growth and metastasis of hepatocellular carcinoma: experiment in vitro].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Zha XL; Liu KD
Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):530-5. PubMed ID: 16681881
[TBL] [Abstract][Full Text] [Related]
4. In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells.
Salvi A; Arici B; Portolani N; Giulini SM; De Petro G; Barlati S
Int J Oncol; 2007 Aug; 31(2):451-60. PubMed ID: 17611703
[TBL] [Abstract][Full Text] [Related]
5. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1.
Jiang Y; Xu W; Lu J; He F; Yang X
Biochem Biophys Res Commun; 2001 Sep; 286(5):1123-30. PubMed ID: 11527416
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
[TBL] [Abstract][Full Text] [Related]
7. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
Li N; Fu H; Tie Y; Hu Z; Kong W; Wu Y; Zheng X
Cancer Lett; 2009 Mar; 275(1):44-53. PubMed ID: 19006648
[TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
[TBL] [Abstract][Full Text] [Related]
9. [The effects of ezrin on the proliferation and the invasiveness of cells of different hepatocellular carcinoma cell lines].
Zhang Y; Hu MY; Chen BH; Wang ZJ; Wu WZ; Zhou K; Liu KD
Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):489-94. PubMed ID: 16867268
[TBL] [Abstract][Full Text] [Related]
10. [Hepatitis B virus X protein regulates c-met promoter via the ERKs singal pathway in HepG2 cells].
Xie B; Tang C; Chen P; Gou YB; Yuan T; Jin SL; Zhou YY
Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):531-4. PubMed ID: 19912689
[TBL] [Abstract][Full Text] [Related]
11. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
[TBL] [Abstract][Full Text] [Related]
12. [The role of FAK expression inhibition by RNA interference on liver cancer cells].
Yuan Z; Zheng Q; Huang XY; Fan J
Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1350-3. PubMed ID: 18241574
[TBL] [Abstract][Full Text] [Related]
13. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation.
Sun CK; Man K; Ng KT; Ho JW; Lim ZX; Cheng Q; Lo CM; Poon RT; Fan ST
Carcinogenesis; 2008 Nov; 29(11):2096-105. PubMed ID: 18765415
[TBL] [Abstract][Full Text] [Related]
14. [Expression of CXCR3 in hepatocellular carcinoma].
Shi M; Guo RP; Zhang CQ; Zhong C; Lin XJ; Li JQ
Ai Zheng; 2006 Oct; 25(10):1232-7. PubMed ID: 17059766
[TBL] [Abstract][Full Text] [Related]
15. [Effects of COX-2 gene silencing by shRNA on biological characteristics of human hepatocellular carcinoma cell line HepG2].
Xu KS; Wang HF; Qian W; Wang BH
Ai Zheng; 2007 Jan; 26(1):32-7. PubMed ID: 17222364
[TBL] [Abstract][Full Text] [Related]
16. Met receptor tyrosine kinase transactivation is involved in proteinase-activated receptor-2-mediated hepatocellular carcinoma cell invasion.
Kaufmann R; Oettel C; Horn A; Halbhuber KJ; Eitner A; Krieg R; Katenkamp K; Henklein P; Westermann M; Böhmer FD; Ramachandran R; Saifeddine M; Hollenberg MD; Settmacher U
Carcinogenesis; 2009 Sep; 30(9):1487-96. PubMed ID: 19546160
[TBL] [Abstract][Full Text] [Related]
17. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
[TBL] [Abstract][Full Text] [Related]
19. [Expressions of the metastasis-associated factors of a new human hepatocellular carcinoma cell line with highly metastatic potential].
Tian J; Tang Z; Xue Q
Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):470-2. PubMed ID: 11715447
[TBL] [Abstract][Full Text] [Related]
20. [Experimental research of targeting hTERT gene inhibited in hepatocellular carcinoma therapy by RNA interference].
Zhang PH; Tu ZG; Yang MQ; Huang WF; Zou L; Zhou YL
Ai Zheng; 2004 Jun; 23(6):619-25. PubMed ID: 15191658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]